Korea University Ansan Hospital

DanwonGu AnsanSi, Gyeonggi-do 15355

1 studies enrolling now · 1 studies all time

What they study most

HR+/HER2- Breast Cancer

Studies at this site

• BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease — Recruiting now